Bimatoprost-Mepha Plus, gtt opht , fl 3 ml

7680669760014 CH-66976 S01ED51
Bimatoprost-Mepha Plus, gtt opht , fl 3 ml
Bimatoprost-Mepha Plus, gtt opht , fl 3 ml
Bimatoprost-Mepha Plus, gtt opht , fl 3 ml
1 / 3
google

Details

Product number
6697601
CPT
-
Packaging group
-
Unit
-

Articles (1)

Bimatoprost-Mepha Plus, Augentropfen
Augentropfen
3
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
12/07/2023
Patient information leaflet
Français
12/07/2023
Patient information leaflet
Italien
12/07/2023
Professional SmPC
Allemand
12/07/2023
Professional SmPC
Français
12/07/2023
Professional SmPC
Italien
12/07/2023

Detailed composition

Substance Quantity Type Category
(N/A)
0.3 MG Substance Wirkstoff (Principe actif)
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance Konservierungsstoff (Conservateur)

Reimbursement information

Public price
CHF 32.90
Specialties list
Yes
Generic
Yes
SL addition date: 01/06/2022

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
66976
Drug name
Bimatoprost-Mepha Plus, Augentropfenlösung
Galenic form
AUGT
ATC Code
S01ED51
Authorization status
Z
Dispensation category
B
First authorization
03/10/2018
Authorization expiration date
31/12/9999
IT number
11.09.0.
Domain
Human medicine
Field of application
Glaukom

Packaging details

Description (FR)
BIMATOPROST Mepha Plus gtt opht fl 3 ml
Description (DE)
BIMATOPROST Mepha Plus Gtt Opht Fl 3 ml
Market launch
03/10/2018
Market withdrawal
25/06/2025
Narcotic (BTM)
No

Original drug

Azarga, Augentropfensuspension
CHF 30.70
View original

Other packaging sizes

BIMATOPROST Mepha Plus gtt opht 3 fl 3 ml
3 x 3 ML
View